MMB-2201 (also known as 5F-MMB-PICA, 5F-AMB-PICA, and I-AMB) is a potent indole-3-carboxamide based synthetic cannabinoid, which has been sold as a designer drug and as an active ingredient in synthetic cannabis blends. It was first reported in Russia and Belarus in January 2014, but has since been sold in a number of other countries. It is the indole core analogue of 5F-AMB. Synthetic cannabinoid compounds with an indole-3-carboxamide or indazole-3-carboxamide core bearing a N-1-methoxycarbonyl group with attached isopropyl or t-butyl substituent, have proved to be much more dangerous than older synthetic cannabinoid compounds previously reported, and have been linked to a large number of deaths in Russia, Japan, Europe and the United States
MMB-2201 is an indole-3-carboxamide based artificial cannabinoid, which has been sold as a smart drug and as an active ingredient in synthetic cannabis mix. It was initially announced in Russia in January 2014, but has since been offered in numerous other countries. It is the indole core analogue of 5F-AMB.
MMB-2201 (also known as 5F-AMB-PICA and I-AMB) is an indole based synthetic cannabinoid, which has been sold as a designer drug and as an active ingredient in synthetic cannabis blends.
MMB2201 is a synthetic cannabinoid that combines methyl valinate with the 1-(5-fluoropentyl)-indole-3-keto subgroup of AM2201 (Item No. 10707). The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
It was first reported in Russia and Belarus in January 2014, but has since been sold in a number of other countries. It is the indole core analogue of 5F-AMB. Synthetic cannabinoid compounds with an indole-3-carboxamide or indazole-3-carboxamide core bearing a N-1-methoxycarbonyl group with attached isopropyl or t-butyl substituent, have proved to be much more dangerous than older synthetic cannabinoid compounds previously reported, and have been linked to a large number of deaths in Russia, Japan, Europe and the United States
MMB-2201 is an indole-3-carboxamide based artificial cannabinoid, which has been sold as a smart drug and as an active ingredient in synthetic cannabis mix. It was initially announced in Russia in January 2014, but has since been offered in numerous other countries. It is the indole core analogue of 5F-AMB.
MMB-2201 (also known as 5F-AMB-PICA and I-AMB) is an indole based synthetic cannabinoid, which has been sold as a designer drug and as an active ingredient in synthetic cannabis blends.
